UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported):     June 28, 2013 

Biologix Hair Inc.

(Exact Name of Registrant as Specified in Its Charter)
 
Nevada   000-54882    27-4588540
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)
 
82 Avenue Road, Toronto, Ontario, Canada   M5R 2H2
(Address of Principal Executive Offices)   (Zip Code)
 
(647) 344-5900

(Registrant’s Telephone Number, Including Area Code)



(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 
 
 
 
Item 5.07.        Submission of Matters to a Vote of Security Holders.
 
On June 28, 2013, Biologix Hair Inc. (the “Company”) held its 2013 Annual Meeting of Stockholders (the "Annual Meeting").  Below is a summary of the proposals and corresponding votes.
 
Proposal One:  The six director nominees received the following votes:
 
Nominee
 
For
   
Withheld
 
Ronald Holland
    42,776,750       --  
Michael Stocker
    42,776,750       --  
Wilhelm A. Keller
    42,776,750       --  
David G. Csumrik
    42,776,750       --  
Ken Zadoorian
    42,776,750       --  
Mark Maybank
    42,776,750       --  
 
There were no broker non-votes on this proposal.
 
Proposal Two:  The ratification of the selection of MNP LLP as the Company's independent registered public accounting firm for the year ending December 31, 2013 received the following votes:
 
For
 
Against
   
Abstain
 
42,576,754
    --       200,000  
 
There were no broker non-votes on this proposal.
 
Proposal Three:  The approval of the 2013 Stock Option Plan.
 
For
 
Against
   
Abstain
 
42,576,754
    --       200,000  
 
There were no broker non-votes on this proposal.
 
 
2

 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

July 1, 2013
BIOLOGIX HAIR INC.
 
     
  /s/ Ronald Holland  
 
Ronald Holland
 
 
Chairman and President
 
 
 
3